Cleared Special

Bashir S-B Endovascular Catheter, Ref. No. 7101 (K192598) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K192598 · Thrombolex, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2019
Decision
28d
Days
Class 2
Risk

K192598 is an FDA 510(k) clearance for the Bashir S-B Endovascular Catheter, Ref. No. 7101. Classified as Mechanical Thrombolysis Catheter (product code QEY), Class II - Special Controls.

Submitted by Thrombolex, Inc. (New Britain, US). The FDA issued a Cleared decision on October 18, 2019 after a review of 28 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.5150 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Thrombolex, Inc. devices

Submission Details

510(k) Number K192598 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 20, 2019
Decision Date October 18, 2019
Days to Decision 28 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
97d faster than avg
Panel avg: 125d · This submission: 28d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code QEY Mechanical Thrombolysis Catheter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.5150
Definition To Mechanically Disrupt Thrombus And/or Debris In The Peripheral Vasculature.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Eminence Clinical Research, Inc.
Diane Horwitz

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - QEY Mechanical Thrombolysis Catheter

All 27
Devices cleared under the same product code (QEY) and FDA review panel - the closest regulatory comparables to K192598.
EKOS PE Endovascular Device with Control System 4.0 (CS4.0)
K200648 · Ekos Corporation · Aug 2020
UNI*FUSE Infusion System with Cooper Wire
K192864 · AngioDynamics, Inc. · Jun 2020
Bashir Plus Endovascular Catheter
K193071 · Thrombolex, Inc. · Dec 2019
EkoSonic Endovascular Device
K191119 · Btg International, Inc. · Aug 2019
EkoSonic Endovascular Device with Control Unit 4.0
K183361 · Btg International, Inc. · Apr 2019
Bashir Endovascular Catheter Model 7201, Bashir N-X Endovascular Catheter, Mode 7200
K183290 · Thrombolex, Inc. · Feb 2019